MedPath

Platelet-Rich Plasma in Acute Muscle Injuries

Phase 2
Completed
Conditions
Muscle Injury
Interventions
Other: Traumeel
Biological: PRP
Registration Number
NCT03676205
Lead Sponsor
University of the Basque Country (UPV/EHU)
Brief Summary

OBJECTIVE: To evaluate the effect of Platelet Rich Plasma (PRP) injection in muscle injuries. The investigators check football players in the acute phase of hamstrings or quadriceps injuries.

Efficacy and safety are evaluated. There are two intramuscular infiltration of PRP (Ortho pras ® system) or a homeopathic product (Traumeel ®) in each of the football players. The number of days between the date of injury and the return to play, the pain, the recurrence and the adverse reactions are registered.

Detailed Description

STUDY DESIGN: Randomized Clinical Trial.

METHODS:

41 football players are included in the study. It is used randomly PRP injection or a homeopathic product in muscle injuries (hamstring), in the early stage (first 48-72 hours).

One week later, the investigators do a second infiltration with the same product, always ultrasound guided. 3-4 weeks after the injury, different variables are evaluated: the injurie with ultrasounds , self-perception test, muscle strength, flexibility, jump and run. It is compared the elapsed time in days in each of the groups: RETURN TO PLAY.

Furthermore, the PAIN, RECURRENCE RATE and ADVERSE REACTIONS are evaluated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • Over 18 years old.
  • Acute muscular Injury Type 3a-3b (Múnich classification) in hamstring muscles
  • Informed consent signed
Exclusion Criteria
  • Hamstring injury (last 6 months).
  • Previous infiltration in hamstring.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Traumel ®Traumeel24-72 hours after having a muscular lesion, the doctor injects an intramuscular ecoguided infiltration of 4 ml of a homeopathic product (Traumeel ®) After 4-5 days from the date of injury, the patient starts physiotherapy adapted by stages, according to the muscular group affected. After 7 days from the first infiltration, the patient will receive the second infiltration of 4 ml of a homeopathic product.
Platelet-Rich PlasmaPRP24-72 hours after having a muscular lesion, the doctor injects an intramuscular ecoguided infiltration of 6-7 ml of PRP . After 4-5 days from the injury the patient starts physiotherapy adapted by stages, according to the muscular group affected. After 7 days from the first infiltration, the patient will recived the second infiltration of 6-7 ml of PRP.
Primary Outcome Measures
NameTimeMethod
Pain intensity3 months since the injury

Pain after the muscle injury, and after the injections, with:

-Funtional outcomes: pain (0 no pain; 10 unbearable pain) at rest, walking and going up and down the stairs.

The Brief Pain Inventory - Short Form. Pain intensity (0, no pain - 10 unbearable) and interferences with the daily activities (0, does not interfere; 10, completely interferes).

Return to play (recovery period)average of 3-6 weeks. Until play again a football match (training or competition)

Days elapsed since muscular injury apperars until the return to play

Secondary Outcome Measures
NameTimeMethod
Number of adverse effectsThrough study completion, an average of 1 year

Any reaction with the product injected

Incidence of RecurrencesLess than 6 months since the first injury

Recurrence: other injury in the same muscle group during the 6 months after the first injury Complication: other injurie or disease in other location of the body (no in the same muscular group).

Trial Locations

Locations (1)

Javier Gonzalez Iglesias

🇪🇸

Bilbao, Bizkaia, Spain

© Copyright 2025. All Rights Reserved by MedPath